HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan Christoph Simon Selected Research

Immunoglobulin G (IgG)

1/2007Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan Christoph Simon Research Topics

Disease

3Psoriasis (Pustulosis Palmaris et Plantaris)
04/2020 - 01/2012
2Melanoma (Melanoma, Malignant)
12/2015 - 04/2015
2Hypersensitivity (Allergy)
09/2011 - 04/2007
2Exanthema (Rash)
01/2007 - 10/2006
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2020
1Hypophysitis
11/2019
1Bullous Pemphigoid (Pemphigoid)
08/2019
1Pemphigus (Pemphigus Vulgaris)
08/2019
1Neoplasms (Cancer)
04/2019
1Lipoma (Lipomata)
04/2019
1Keratoacanthoma
12/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2015
1Hyperplasia
04/2015
1Carcinoma (Carcinomatosis)
04/2015
1Edema (Dropsy)
01/2014
1Erythema
01/2014
1Pain (Aches)
01/2014
1Ulcer
12/2010
1Wounds and Injuries (Trauma)
12/2010
1Elephantiasis
01/2010
1Hypertrichosis
08/2008
1Hemangioma (Angioma)
08/2008
1Lentigo (Lentiginosis)
08/2008
1Cicatrix (Scar)
08/2008
1Nevus (Nevi)
08/2008
1Nevus of Ota
08/2008
1Pigmentation Disorders (Ito Syndrome)
08/2008
1Telangiectasis (Telangiectasia)
08/2008
1Basal Cell Carcinoma (Rodent Ulcer)
02/2007
1Bacterial Infections (Bacterial Infection)
01/2002
1Inflammation (Inflammations)
01/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
04/2020 - 10/2006
1Ustekinumab (CNTO 1275)FDA Link
04/2020
1secukinumabIBA
08/2019
1Interleukin-17 (Interleukin 17)IBA
08/2019
1Indicators and Reagents (Reagents)IBA
04/2019
1calcipotriene (calcipotriol)FDA LinkGeneric
01/2012
1Anthralin (Dithranol)IBA
01/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2011
1flupirtineIBA
09/2011
1Disinfectants (Biocides)IBA
12/2010
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2010
1Aluminum SilicatesIBA
01/2010
1beta-LactamsIBA
04/2007
1Immunoglobulin E (IgE)IBA
04/2007
1AllergensIBA
04/2007
1Immunoglobulin G (IgG)IBA
01/2007
1Immunoglobulin A (IgA)IBA
01/2007
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2007
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2006
1LigandsIBA
01/2002
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2002
1Hyaluronic Acid (Hyaluronan)IBA
01/2002
1Polysaccharides (Glycans)IBA
01/2002

Therapy/Procedure

4Therapeutics
12/2015 - 12/2010
3Lasers (Laser)
01/2014 - 08/2008
2Solid-State Lasers
01/2014 - 08/2008
1Immunotherapy
11/2019
1Semiconductor Lasers
01/2014
1Aftercare (After-Treatment)
01/2012
1Excimer Lasers
01/2012
1Debridement
12/2010
1Tattooing
08/2008
1Operative Surgical Procedures
02/2007